JAX helps put a cap on breast cancer

JAX Tyres & Auto at Charmhaven will join with the other 92 JAX stores across the country in supporting the National Breast Cancer Foundation (NBCF) and its vision of Zero Deaths from breast cancer.

The Put a Cap on Breast Cancer campaign will run at all JAX stores until the end of October.

The campaign first launched in 2023 and has already raised just short of $30,000 to support world-class research focused on precision prevention, the early detection of breast cancer, stopping the progression and recurrence of breast cancer, and treating hard-to-treat and metastatic breast cancer – research that ultimately saves lives.

Until the end of October, JAX Charmhaven will have pink caps available and will be encouraging customers to swap their regular tyre valve caps to the pink tyre valve caps to raise awareness of breast cancer and show support to those diagnosed, with all donations going directly to NCBF.

There will be 21,000 pink valve caps available nationwide to represent the 21,000 Australians diagnosed with breast cancer every year.

Since its inception in 1994, NBCF has invested more than $200M into 600-plus world-class research projects , with the death rate from breast cancer being reduced by over 40% in that time frame.

JAX Tyres & Auto Chief Franchising Support Officer April Harwood said the company was proud to support NBCF’s mission for Zero Deaths from breast cancer.

“This is our third year of working with the National Breast Cancer Foundation and signing up again, after the success of the two previous years, was a no-brainer,” she said.

National Breast Cancer Foundation CEO, Associate Professor Cleola Anderiesz, said JAX had a significant network across Australia and she hoped this year’s Put A Cap on Breast Cancer campaign would be the most successful yet.

“Our vision is simple – we want to end deaths from breast cancer in Australia,” she said.

“We’ve made significant progress and are very grateful for the support of JAX Tyres & Auto and other organisations for their support of breast cancer research, but we recognise that the job’s not done yet.”